Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Article in Medicinal Research Reviews (September 2022)
The most recent citing publication is shown below. View this citation on Dimensions.
Frontiers in Clinical Neuroscience
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Advances in Neuroprotection Research for Neurodegenerative Diseases
-
Altmetric BadgeChapter 2 Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-Gaba Interaction
-
Altmetric BadgeChapter 3 Neuroprotection in Ischemic/Hypoxic Disorders
-
Altmetric BadgeChapter 4 Neuroprotection and Dopamine Agonists
-
Altmetric BadgeChapter 5 COMT Inhibition in the Treatment of Parkinson’S Disease: Neuroprotection and Future Perspectives
-
Altmetric BadgeChapter 6 Neuroprotection and Epilepsy
-
Altmetric BadgeChapter 7 Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis.
-
Altmetric BadgeChapter 8 Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications
-
Altmetric BadgeChapter 9 Neuroprotection: A Realistic Goal for Aged Brain?
-
Altmetric BadgeChapter 10 Kynurenines in neurodegenerative disorders: therapeutic consideration.
Attention for Chapter 8:
Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications